BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 26308244)

  • 1. Revisiting determinants of prognosis in cutaneous melanoma.
    Weiss SA; Hanniford D; Hernando E; Osman I
    Cancer; 2015 Dec; 121(23):4108-23. PubMed ID: 26308244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
    Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
    JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current staging and prognostic factors in melanoma.
    Bartlett EK; Karakousis GC
    Surg Oncol Clin N Am; 2015 Apr; 24(2):215-27. PubMed ID: 25769707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis.
    Donizy P; Kaczorowski M; Leskiewicz M; Zietek M; Pieniazek M; Kozyra C; Halon A; Matkowski R
    Oncol Rep; 2014 Dec; 32(6):2735-43. PubMed ID: 25310673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
    Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
    J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma Intergroup.
    Patuzzo R; Mattavelli I; Gallino G; Galeone C; Valeri B; Mocellin S; Del Fiore P; Ribero S; Mandalà M; Tauceri F; Lombardo M; Maurichi A;
    Cancer; 2023 Aug; 129(15):2331-2340. PubMed ID: 37162404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXP3+ cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma.
    Ladányi A; Mohos A; Somlai B; Liszkay G; Gilde K; Fejos Z; Gaudi I; Tímár J
    Pathol Oncol Res; 2010 Sep; 16(3):303-9. PubMed ID: 20306313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic molecular biomarkers for cutaneous malignant melanoma.
    Tanaka R; Koyanagi K; Narita N; Kuo C; Hoon DS
    J Surg Oncol; 2011 Sep; 104(4):438-46. PubMed ID: 21557225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging and prognosis of cutaneous melanoma.
    Dickson PV; Gershenwald JE
    Surg Oncol Clin N Am; 2011 Jan; 20(1):1-17. PubMed ID: 21111956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new melanoma staging system.
    Kim CJ; Reintgen DS; Balch CM;
    Cancer Control; 2002; 9(1):9-15. PubMed ID: 11907461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients.
    Greenhaw BN; Covington KR; Kurley SJ; Yeniay Y; Cao NA; Plasseraud KM; Cook RW; Hsueh EC; Gastman BR; Wei ML
    J Am Acad Dermatol; 2020 Sep; 83(3):745-753. PubMed ID: 32229276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic staging of melanoma.
    Ruiter DJ; Spatz A; van den Oord JJ; Cook MG;
    Semin Oncol; 2002 Aug; 29(4):370-81. PubMed ID: 12170440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
    Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
    Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
    Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
    Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.
    Balch CM; Buzaid AC; Soong SJ; Atkins MB; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF
    J Clin Oncol; 2001 Aug; 19(16):3635-48. PubMed ID: 11504745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
    Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
    Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors.
    Waninger JJ; Ma VT; Journey S; Skvarce J; Chopra Z; Tezel A; Bryant AK; Mayo C; Sun Y; Sankar K; Ramnath N; Lao C; Sussman JB; Fecher L; Alva A; Green MD
    JAMA Netw Open; 2021 Mar; 4(3):e210980. PubMed ID: 33687443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of the 2001 AJCC staging system for cutaneous malignant melanoma.
    Schuchter LM
    Curr Oncol Rep; 2001 Jul; 3(4):332-7. PubMed ID: 11389818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastases.
    Chatziioannou E; Roßner J; Aung TN; Rimm DL; Niessner H; Keim U; Serna-Higuita LM; Bonzheim I; Kuhn Cuellar L; Westphal D; Steininger J; Meier F; Pop OT; Forchhammer S; Flatz L; Eigentler T; Garbe C; Röcken M; Amaral T; Sinnberg T
    EBioMedicine; 2023 Jul; 93():104644. PubMed ID: 37295047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.